- Resources
Femara (letrozole) Side Effects
- Femara Oral Precautions and Side Effects
- Dosage and Storage
- Precautions and Side Effects
- Drug Interactions
Pronounced: (LET-tro-zole)
Side Effects
Hot flashes, hair loss, joint/bone/muscle pain, tiredness, unusual sweating, nausea, diarrhea, dizziness, and trouble sleeping may occur. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not...
Read moreMore information on "Femara (letrozole) Side Effects"
From Our Experts
Aromatase Inhibitor FAQs: Hormone Therapy (Arimidex, Femara, and...
Q. I've been on tamoxifen for a couple of years, and now my doctor is switching me to an aromatase inhibitor. I understand how... Read more »
An Oncologist's Thoughts on the Canceled Breast Cancer Prevention...
Earlier this summer, the National Institutes of Health decided not to fund a breast cancer prevention trial to test Letrozole (Femara), an... Read more »
Soy for Hot Flashes? Read This First
Do you take an aromatase inhibitor (Femara, Arimidex, Aromasin) to prevent breast cancer recurrence? Do you also take one of those... Read more »
Osteoporosis after Breast Cancer
Lila de Tantillo, an expert from our partner site OsteoporosisConnection.com, discusses osteoporosis as a side effect of breast cancer... Read more »
New Treatment for HER2+ Survivors
For certain women with metastatic HER2+ breast cancer, life just got a little bit brighter – literally. On January 29, the FDA granted... Read more »
From Our Sources
Femara
Source: Breastcancer.org
Femara (chemical name: letrozole) is an aromatase inhibitor approved by the U.S. Food and Drug Administration (FDA) to treat: post-menopausal women... Read more »
Femara
Source: Breastcancer.org
Brand name: Femara Chemical name: Letrozole Class: Aromatase inhibitor hormonal therapy. Aromasin and Arimidex are other aromatase inhibitors. How it... Read more »
Femara beats Tamoxifen for older breast cancer patients
A new study has found that letrozole (Femara) increases survival more than tamoxifen for postmenopausal women who have undergone surgery. In the... Read more »
Tykerb
Source: Breastcancer.org
Tykerb (chemical name: lapatinib) has been approved by the U.S. Food and Drug Administration (FDA): to be given in combination with Xeloda (chemical... Read more »
Chemotherapy for Breast Cancer
Source: ADAM Encyclopedia
Hormone TherapyThe goal of hormone therapy is to prevent estrogen from stimulating breast cancer cells. It is recommended for women whose breast... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
